Sitesinformation.com

Keyword Analysis & Research: fintelpa


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
fintelpa0.990.84535418

Keyword Research: People who searched fintelpa also searched

Keyword CPC PCC Volume Score
fintelpa1.310.9349629
fintelpa lobbyist groups0.711612911
fintelpa rems1.360.5217875

Search Results related to fintelpa on Search Engine

  • Fintepla: Uses, Instructions, Side Effects, Warnings - Drugs.com

    drugs.com

    https://www.drugs.com/fintepla.html

    WEBFintepla is a prescription medicine used to treat the seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older. Fintepla is a federally controlled substance (C-IV) because it contains fenfluramine. Keep this medicine in a safe place to prevent misuse and abuse, and to protect it from theft.

    DA: 100 PA: 97 MOZ Rank: 99 Up or Down: Up

  • FINTEPLA® (fenfluramine) oral solution | Treatment for Seizures

    finteplahcp.com

    https://www.finteplahcp.com/

    WEBFINTEPLA® (fenfluramine) oral solution | Treatment for Seizures Associated With Dravet Syndrome & LGS. For your patients ≥2 years of age experiencing seizures associated with Dravet syndrome or Lennox-Gastaut syndrome (LGS) Write your next success story for patients with Dravet syndrome or LGS. FINTEPLA for Dravet syndrome. FINTEPLA for …

    DA: 81 PA: 87 MOZ Rank: 52 Up or Down: Up

  • Fintepla Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD

    webmd.com

    https://www.webmd.com/drugs/2/drug-179643/fintepla-oral/details

    WEBFintepla 2.2 Mg/Ml Oral Solution Amphetamines/Anorexiants/Stimulants - Uses, Side Effects, and More. Generic Name (S): fenfluramine. Uses. Precautions. Uses. Fenfluramine is used to help control...

    DA: 89 PA: 34 MOZ Rank: 7 Up or Down: Up

  • Fintepla (fenfluramine): Uses, Side Effects, Dosage & Reviews - GoodRx

    goodrx.com

    https://www.goodrx.com/fintepla/what-is

    WEBFeb 13, 2023 · Fintepla. fenfluramine. Used for Epilepsy. Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older. This medication is only meant for those with seizures caused by Dravet syndrome or Lennox-Gastaut syndrome, not other seizure conditions.

    DA: 37 PA: 70 MOZ Rank: 20 Up or Down: Up

  • Fintepla: Uses, Taking, Side Effects, Warnings - Medicine.com

    medicine.com

    https://www.medicine.com/drug/fintepla

    WEBWhat is Fintepla? Fintepla is a prescription medicine used to treat the seizures associated with Dravet syndrome in patients 2 years of age and older. Fintepla is a federally controlled substance (C-IV) because it contains fenfluramine. Keep Fintepla in a safe place to prevent misuse, abuse, and protect it from theft.

    DA: 83 PA: 76 MOZ Rank: 100 Up or Down: Up

  • Fintepla | European Medicines Agency

    europa.eu

    https://www.ema.europa.eu/en/medicines/human/EPAR/fintepla

    WEBOct 16, 2020 · Fintepla is a medicine used in addition to other epilepsy medicines to treat patients from 2 years of age who have Dravet syndrome or Lennox-Gastaut syndrome, types of epilepsy that begin in childhood and continue into adulthood. These conditions are rare, and Fintepla was designated an ‘ orphan medicine ’ (a medicine used in rare …

    DA: 14 PA: 5 MOZ Rank: 30 Up or Down: Up

  • U.S. FDA Approves FINTEPLA[®] (fenfluramine) Oral Solution for …

    ucb.com

    https://www.ucb.com/stories-media/Press-Releases/article/US-FDA-Approves-FINTEPLAR-Vfenfluramine-Oral-Solution-for-Treatment-of-Seizures-Associated-with-Lennox-Gastaut-Syndrome-LGS

    WEBMar 28, 2022 · Brussels (Belgium), and Atlanta, Ga. (USA) 28 March 2022 – 7 a.m. CET – UCB (Euronext: UCB), a global biopharmaceutical company, today announced that FINTEPLA ® (fenfluramine) oral solution CIV has been approved in the United States, by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated …

    DA: 82 PA: 97 MOZ Rank: 35 Up or Down: Up

  • FDA Approves New Therapy for Dravet Syndrome | FDA

    fda.gov

    https://www.fda.gov/news-events/press-announcements/fda-approves-new-therapy-dravet-syndrome

    WEBJun 25, 2020 · FDA approves Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older.

    DA: 7 PA: 33 MOZ Rank: 65 Up or Down: Up

  • FINTEPLA® (fenfluramine) Oral Solution Now FDA Approved for …

    prnewswire.com

    https://www.prnewswire.com/news-releases/fintepla-fenfluramine-oral-solution-now-fda-approved-for-treatment-of-seizures-associated-with-lennox-gastaut-syndrome-lgs-301511407.html

    WEBMar 28, 2022 · FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older. IMPORTANT SAFETY INFORMATION....

    DA: 92 PA: 59 MOZ Rank: 81 Up or Down: Up

  • Fintepla ( fenfluramine - European Medicines Agency

    europa.eu

    https://www.ema.europa.eu/en/documents/overview/fintepla-epar-medicine-overview_en.pdf

    WEBWhat is Fintepla and what is it used for? Fintepla is a medicine used in addition to other epilepsy medicines to treat patients from 2 years of age who have Dravet syndrome or Lennox-Gastaut syndrome, types of epilepsy that begin in …

    DA: 83 PA: 94 MOZ Rank: 99 Up or Down: Up